Trade VRTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Vertex Pharmaceuticals Incorporated (VRTX) is trading at US$510.08, up 1.36% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$138.91B. Over the past 52 weeks, VRTX has traded between US$402.58 and US$560.25. On Syfe you can trade VRTX with $0 commission and add it to your watchlist.
| Previous close | US$503.25 |
|---|---|
| Market cap | US$138.91B |
| P/E ratio | 24.81 |
| 52-week range | US$402.58 – US$560.25 |
| Volume | 1.42M |
| Exchange | US |
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Year: 1991
Vertex Pharmaceuticals Incorporated (VRTX) stock is trading at US$510.08, +1.36% from the previous close of US$503.25.
The market cap for Vertex Pharmaceuticals Incorporated (VRTX) stock is approximately US$138.91B.
The price-to-earnings ratio for Vertex Pharmaceuticals Incorporated (VRTX) is 24.81, based on the latest reported earnings.
The 52-week high for Vertex Pharmaceuticals Incorporated (VRTX) stock is US$560.25.
The 52-week low for Vertex Pharmaceuticals Incorporated (VRTX) stock is US$402.58.
Vertex Pharmaceuticals Incorporated (VRTX) does not currently pay a dividend.
Stay on top of VRTX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
